These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. COVID-19 PCR Test, Cluster of False Positive and Importance of Quality Control. Joob B; Wiwantikit V Clin Lab; 2020 Oct; 66(10):. PubMed ID: 33073939 [No Abstract] [Full Text] [Related]
24. The utility of beta-2-microglobulin testing as a human cellular control in COVID-19 testing. Davies E; Whitfield T; Machin N; Ahmad S J Clin Virol; 2020 Aug; 129():104449. PubMed ID: 32504943 [No Abstract] [Full Text] [Related]
26. The Brief Case: "Not Positive" or "Not Sure"-COVID-19-Negative Results in a Symptomatic Patient. Parikh BA; Bailey TC; Lyons PG; Anderson NW J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32703891 [No Abstract] [Full Text] [Related]
27. Diagnostic Stewardship: An Essential Element in a Rapidly Evolving COVID-19 Pandemic. Shah AS; Tande AJ; Challener DW; O'Horo JC; Binnicker MJ; Berbari EF Mayo Clin Proc; 2020 Sep; 95(9S):S17-S19. PubMed ID: 32807516 [No Abstract] [Full Text] [Related]
28. Establishing a healthcare worker screening programme for COVID-19. Boustead K; McDowall K; Baker KF; Pareja-Cebrian L; Gibson L; Cunningham M; Murphy E Occup Med (Lond); 2020 Oct; 70(7):456-457. PubMed ID: 32569369 [No Abstract] [Full Text] [Related]
29. Inner Workings: Molecular biologists offer "wartime service" in the effort to test for COVID-19. McDermott A Proc Natl Acad Sci U S A; 2020 May; 117(18):9656-9659. PubMed ID: 32295880 [No Abstract] [Full Text] [Related]
30. How ADA methodology informs SARS-CoV-2 assay development. Becker C Bioanalysis; 2020 Sep; 12(18):1275-1277. PubMed ID: 32915061 [No Abstract] [Full Text] [Related]
32. Is reinfection possible after recovery from COVID-19? Law SK; Leung AWN; Xu C Hong Kong Med J; 2020 Jun; 26(3):264-265. PubMed ID: 32536614 [No Abstract] [Full Text] [Related]
33. University participation in the production of molecular diagnostic tests for the novel coronavirus in Brazil: the response to health challenges. Silva RGLD; Chammas R; Plonski GA; Goldbaum M; Ferreira LCS; Novaes HMD Cad Saude Publica; 2020; 36(6):e00115520. PubMed ID: 32609169 [No Abstract] [Full Text] [Related]
35. The Challenges of Expanding Rapid Tests to Curb COVID-19. Rubin R JAMA; 2020 Nov; 324(18):1813-1815. PubMed ID: 33084882 [No Abstract] [Full Text] [Related]
36. Comparison of Abbott ID Now, DiaSorin Simplexa, and CDC FDA Emergency Use Authorization Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Individuals Diagnosed with COVID-19. Rhoads DD; Cherian SS; Roman K; Stempak LM; Schmotzer CL; Sadri N J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32303564 [No Abstract] [Full Text] [Related]
37. Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Assay for the Detection of SARS-CoV-2 in Oropharyngeal Swab Specimens. Hou H; Chen J; Wang Y; Lu Y; Zhu Y; Zhang B; Wang F; Mao L; Tang YW; Hu B; Ren Y; Sun Z J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32503847 [No Abstract] [Full Text] [Related]
38. Shifting sands-Molecular coronavirus testing during a time of inconsistent resources. Henderson DK; Hayden MK; Wright SB; Weber DJ; Murthy AR; Babcock H; Guzman-Cottrill JA; Haessler S; Rock C; Van Schooneveld T; Forde CA; Logan LK; Malani A; Infect Control Hosp Epidemiol; 2020 Oct; 41(10):1190-1191. PubMed ID: 32498736 [No Abstract] [Full Text] [Related]
39. A COVID-19 Patient with Repeatedly Undetectable SARS-CoV-2 Antibodies. Goetz L; Yang J; Greene W; Zhu Y J Appl Lab Med; 2020 Nov; 5(6):1401-1405. PubMed ID: 32745181 [No Abstract] [Full Text] [Related]
40. Testing for SARS-CoV-2 (COVID-19): A General Review. Tang EW; Bobenchik AM; Lu S R I Med J (2013); 2020 Sep; 103(8):20-23. PubMed ID: 32900007 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]